Search Results - "Kurie, Jonathan"
-
1
The fibrotic tumor stroma
Published in The Journal of clinical investigation (02-01-2018)“…Intratumoral fibrosis results from the deposition of a cross-linked collagen matrix by cancer-associated fibroblasts (CAFs). This type of fibrosis has been…”
Get full text
Journal Article -
2
Smoking, p53 mutation, and lung cancer
Published in Molecular cancer research (01-01-2014)“…This issue marks the 50th anniversary of the release of the U.S. Surgeon General's Report on Smoking and Health. Perhaps no other singular event has done more…”
Get full text
Journal Article -
3
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
Published in Nature communications (09-09-2020)“…Tumor extracellular matrix has been associated with drug resistance and immune suppression. Here, proteomic and RNA profiling reveal increased collagen levels…”
Get full text
Journal Article -
4
The cancer-associated secretory phenotype: a new frontier in targeted therapeutics
Published in The Journal of clinical investigation (01-09-2024)“…Tan discusses the cancer-associated secretory phenotypes (CASPs). Somatic mutations activate CASPs by initiating cargo-specific secretory vesicle biogenesis in…”
Get full text
Journal Article -
5
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Published in Nature communications (28-10-2014)“…Immunosuppression of tumour-infiltrating lymphocytes (TIL) is a common feature of advanced cancer, but its biological basis has remained obscure. We…”
Get full text
Journal Article -
6
Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer
Published in Matrix biology (01-09-2020)“…Tumor progression is marked by dense collagenous matrix accumulations that dynamically reorganize to accommodate a growing and invasive tumor mass…”
Get full text
Journal Article -
7
Analysis of Golgi Secretory Functions in Cancer
Published in Methods in molecular biology (Clifton, N.J.) (2023)“…Cancer cells utilize secretory pathways for paracrine signaling and extracellular matrix remodeling to facilitate directional cell migration, invasion, and…”
Get more information
Journal Article -
8
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
Published in Genes & development (15-09-2009)“…Metastatic disease is a primary cause of cancer-related death, and factors governing tumor cell metastasis have not been fully elucidated. Here, we address…”
Get full text
Journal Article -
9
EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer
Published in The Journal of clinical investigation (01-04-2023)“…Hypersecretory malignant cells underlie therapeutic resistance, metastasis, and poor clinical outcomes. However, the molecular basis for malignant…”
Get full text
Journal Article -
10
BMP4 depletion by miR-200 inhibits tumorigenesis and metastasis of lung adenocarcinoma cells
Published in Molecular cancer (22-09-2015)“…MicroRNA-200 (miR-200) suppresses the epithelial-mesenchymal transition of various cancer cells, including lung adenocarcinoma cells. We found that bone…”
Get full text
Journal Article -
11
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
Published in Proceedings of the National Academy of Sciences - PNAS (20-02-2018)“…Polo-like kinase 4 (PLK4) is a serine/threonine kinase regulating centriole duplication. CFI-400945 is a highly selective PLK4 inhibitor that deregulates…”
Get full text
Journal Article -
12
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer
Published in Molecular cancer therapeutics (01-10-2017)“…Molecularly targeted drugs have yielded significant therapeutic advances in oncogene-driven non-small cell lung cancer (NSCLC), but a majority of patients…”
Get full text
Journal Article -
13
Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC
Published in Journal of thoracic oncology (01-02-2020)“…Consolidation durvalumab after chemoradiation (CRT) is the current standard of care for locally advanced NSCLC. We hypothesized that adding immunotherapy…”
Get more information
Journal Article -
14
Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma
Published in Molecular cancer research (01-03-2016)“…Intratumoral collagen cross-links heighten stromal stiffness and stimulate tumor cell invasion, but it is unclear how collagen cross-linking is regulated in…”
Get full text
Journal Article -
15
The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cells
Published in Nature communications (03-11-2021)“…Epithelial-to-mesenchymal transition (EMT) is a transcriptionally governed process by which cancer cells establish a front-rear polarity axis that facilitates…”
Get full text
Journal Article -
16
A Method for Orthotopic Transplantation of Lung Cancer in Mice
Published in Methods in molecular biology (Clifton, N.J.) (2022)“…Preclinical mouse models of lung cancer have been vital experimental tools to elucidate cancer biology and test novel therapeutic regimens. Two main models are…”
Get more information
Journal Article -
17
Addiction to Golgi-resident PI4P synthesis in chromosome 1q21.3–amplified lung adenocarcinoma cells
Published in Proceedings of the National Academy of Sciences - PNAS (22-06-2021)“…A chromosome 1q21.3 region that is frequently amplified in diverse cancer types encodes phosphatidylinositol (PI)-4 kinase IIIβ (PI4KIIIβ), a key regulator of…”
Get full text
Journal Article -
18
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth
Published in Molecular cancer research (01-04-2021)“…Ubiquitin specific peptidase 18 (USP18), previously known as UBP43, is the IFN-stimulated gene 15 (ISG15) deconjugase. USP18 removes ISG15 from substrate…”
Get full text
Journal Article -
19
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC
Published in Journal of thoracic oncology (01-09-2020)“…Programmed death-ligand 1 (PD-L1) expression may vary in different disease sites and at different time points of the disease course. We aimed to investigate…”
Get more information
Journal Article -
20
Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11
Published in The Journal of clinical investigation (01-01-2017)“…Tumor cells gain metastatic capacity through a Golgi phosphoprotein 3-dependent (GOLPH3-dependent) Golgi membrane dispersal process that drives the budding and…”
Get full text
Journal Article